Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MERCAPTOPURINE Cause Diffuse large b-cell lymphoma? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Diffuse large b-cell lymphoma have been filed in association with MERCAPTOPURINE (Mercaptopurine). This represents 0.2% of all adverse event reports for MERCAPTOPURINE.

28
Reports of Diffuse large b-cell lymphoma with MERCAPTOPURINE
0.2%
of all MERCAPTOPURINE reports
4
Deaths
5
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From MERCAPTOPURINE?

Of the 28 reports, 4 (14.3%) resulted in death, 5 (17.9%) required hospitalization, and 3 (10.7%) were considered life-threatening.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MERCAPTOPURINE. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does MERCAPTOPURINE Cause?

Febrile neutropenia (1,853) Off label use (893) Pyrexia (855) Drug ineffective (721) Vomiting (488) Neutropenia (485) Nausea (418) Pneumonia (394) Pancytopenia (392) Sepsis (389)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which MERCAPTOPURINE Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

MERCAPTOPURINE vs MEROPENEM MERCAPTOPURINE vs MEROPENEM ANHYDROUS MERCAPTOPURINE vs MESALAMINE MERCAPTOPURINE vs MESNA MERCAPTOPURINE vs METAMIZOLE

Related Pages

MERCAPTOPURINE Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma MERCAPTOPURINE Demographics